VANGUARD GROUP INC 13D and 13G filings for Edwards Lifesciences Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-30 9:34 pm Purchase | 2024-12-31 | 13G | Edwards Lifesciences Corporation EW | VANGUARD GROUP INC | 69,131,602 11.720% | 6,537,494 (+10.44%) | Filing |
| 2024-10-04 2:14 pm Purchase | 2024-09-30 | 13G | Edwards Lifesciences Corporation EW | VANGUARD GROUP INC | 62,594,108 10.390% | 10,231,195 (+19.54%) | Filing |
| 2024-02-13 5:04 pm Purchase | 2023-12-29 | 13G | Edwards Lifesciences Corporation EW | VANGUARD GROUP INC | 52,362,913 8.630% | 803,522 (+1.56%) | Filing |
| 2023-02-09 11:16 am Purchase | 2022-12-30 | 13G | Edwards Lifesciences Corporation EW | VANGUARD GROUP INC | 51,559,391 8.340% | 2,482,742 (+5.06%) | Filing |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | Edwards Lifesciences Corporation EW | VANGUARD GROUP INC | 49,076,649 7.860% | 728,964 (+1.51%) | Filing |
| 2021-02-10 10:52 am Sale | 2020-12-31 | 13G | Edwards Lifesciences Corporation EW | VANGUARD GROUP INC | 48,347,685 7.760% | -437,421 (-0.90%) | Filing |